Lundbeckfonden

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 15, 2022	NMD Pharma	$39.6M Other Equity	Sabine Dandiguian	Roel Bulthuis, Novo Holdings, Roche
Mar 1, 2019	SNIPR Biome	$50.0M Series A	Joachim Rothe, Lundbeckfonden	AbbVie Ventures, Agent Capital, MRL Ventures Fund, Wellington Partners

Total Raised

N/A

Valuation

N/A